Paul Friedman

Board Member

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

MDGL

Current role

Board Member, CEO

1 call Latest call 2022-05-09

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Madrigal Pharmaceuticals, Inc. (MDGL)	Former Chief Executive Officer	$498,846	—	$7,999,867	—	—	$1,064,573	$9,563,286
2022	Madrigal Pharmaceuticals, Inc. (MDGL)	Former Chief Executive Officer	$658,021	—	—	$4,239,900	$497,464	—	$5,395,385
2021	Madrigal Pharmaceuticals, Inc. (MDGL)	Former Chief Executive Officer	$627,650	—	—	$4,267,500	$423,239	—	$5,318,389
2020	Madrigal Pharmaceuticals, Inc. (MDGL)	Chairman and Chief Executive Officer	$603,500	—	—	$3,468,500	$463,446	—	$4,535,446
2019	Madrigal Pharmaceuticals, Inc. (MDGL)	Chairman and Chief Executive Officer	$584,000	—	—	$5,122,000	$387,192	—	$6,093,192
2018	Madrigal Pharmaceuticals, Inc. (MDGL)	Chairman and Chief Executive Officer	$416,666	—	—	$4,907,500	$304,500	—	$5,628,666
2017	Madrigal Pharmaceuticals, Inc. (MDGL)	Chairman and Chief Executive Officer	$400,000	—	—	$629,424	$335,000	$558	$1,364,982

Earnings-call appearances and filed executive appointments or departures, newest first.